The newly approved oral formulation features a smaller pill size in 1.5mg, 4mg, and 9mg strengths while maintaining the efficacy and safety profile of the previous oral semaglutide version.

We worked with testers, whose identities we have verified, to test the products and services mentioned in this story. Due to ...

Novo Nordisk (NVO) stock is in focus as the company launches oral semaglutide as Ozempic pill for patients with type 2 ...

A Lancet trial found weekly semaglutide injections reduced heavy drinking in adults with obesity and alcohol use disorder.

Health Canada has approved Dr. Reddy’s Laboratories’ generic version of semaglutide, making Canada the first G7 nation to authorise such a product. The drug, used for once-weekly treatment of Type 2 ...

Dr Reddy's Laboratories has received approval from Health Canada to sell a generic version of the diabetes drug semaglutide, ...

The global obesity drugs market is projected to grow at a robust compound annual growth rate (CAGR) of approximately 25% ...

Dr Reddy’s Laboratories has received early approval from Health Canada to market its generic semaglutide injection, the first ...

As many of us know, keeping weight in check can be hard. National numbers certainly reflect this. Rates of overweight and ...

Dr. Reddy’s Laboratories (DRL) has secured Health Canada's first-ever generic Semaglutide approval, targeting the world's ...

Phase 3 trial data show a synthetic semaglutide injection provides glycemic control comparable to Ozempic in patients with type 2 diabetes.